Patent · US Active

Antiviral immunotherapy by membrane receptor ligation

US11208469B2 · kind B2 · utility

0Cited by

4References

3Claims

0Family size

Assignee

Eberhard Karls Universitaet Tuebingen Medizinische Fakultaet · DE

Inventors

Michael Schindler · Wallsend, GB
Marius Codrea · Lörrach, DE
Sven Nahnsen · Lörrach, DE
Herwig Koppensteiner · Wien, AT
Gundram Jung · Rottenburg am Neckar, DE
Martin Hofmann · Lörrach, DE

Key dates

Filing date	Sep 14, 2018
Grant date	Dec 28, 2021
Priority date	—
Expiry date	Sep 14, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/75
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a cytotoxic agent for the prophylaxis and/or treatment of a viral infection which is configured for the selective binding to a membrane receptor of virus-infected T lymphocytes, a pharmaceutical composition containing said cytotoxic agent, the use of the cytotoxic agent for the prophylaxis and/or treatment of viral infections, a method of finding cytotoxic agents, the use of a membrane receptor of virus-infected T lymphocytes which is overexpressed in comparison to non-infected T lymphocytes for the diagnosis of a viral infection.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.